Table 2.
Demographic characteristics, clinical information, and lab data of patients (N = 67). No significant differences between responder and poor responder in patient's characteristics were observed at all times by 20 µM ADP (P > 0.05).
| Total |
ADP 20 µM
|
|||||||
|---|---|---|---|---|---|---|---|---|
|
2 h
|
24 h
|
30 days
|
||||||
| P f | R g | P | R | P | R | |||
| Age (year), mean ± SD | 57.78 ± 10.80 | 58.22 ± 9.65 | 57.39 ± 11.79 | 57.46 ± 10.26 | 58.00 ± 11.17 | 56.87 ± 8.31 | 58.20 ± 11.65 | |
| Sez | 47 (70.1) | 22 (46.8) | 25 (53.2) | 10 (21.7) | 36 (78.3) | 12 (26.1) | 34 (73.9) | 29 (64.4) |
| 20 (29.9) | 9 (45.0) | 11 (55.0) | 3 (15.8) | 16 (84.2) | 3 (15.8) | 16 (84.2) | 14 (73.7) | |
| Smoking, NO (%) | 27 (40.3) | 12 (44.4) | 15 (55.6) | 5 (18.5) | 22 (81.5) | 5 (18.5) | 22 (81.5) | |
| Diabetes Mellitus, NO (%) | 14 (20.9) | 6 (42.9) | 8 (57.1) | 3 (21.4) | 11 (78.6) | 2 (14.3) | 12 (85.7) | |
| HTNa (BP ≥140/90 mmHg), NO (%) | 32 (47) | 16 (50.0) | 16 (50.0) | 6 (18.8) | 26 (81.2) | 9 (28.1) | 23 (71.9) | |
| Hyperlipidemia (LDL-C≥100 mg/dL), NO (%) | 49 (73.1) | 20 (40.8) | 29 (59.2) | 10 (20.8) | 38 (79.2) | 13 (27.1) | 35 (72.9) | |
| BMIb (kg/m2), mean ± SD | 26.25 ± 4.02 | 27.48 ± 4.50 | 25.26 ± 4.34 | 26.45 ± 3.91 | 25.25 ± 3.34 | 27.48 ± 4.20 | 26.07 ± 3.99 | |
| LVEFc<45%, NO (%) | 6 (9.0) | 1 (16.7) | 5 (83.3) | 0 (0.0) | 6 (100.0) | 0 (0.0) | 6 (100.0) | |
| WBCd (× 1000/µL), mean ± SD | 7.28 ± 2.16 | 7.12 ±1.70 | 7.42 ± 2.51 | 8.14 ± 3.29 | 7.00 ± 1.76 | 8.31 ± 2.87 | 6.90 ± 1.82 | |
| PLTe (× 1000/µL), mean ± SD | 229.9 ± 67.48 | 219.42 ± 60.54 | 239.00 ± 72.54 | 232.69 ± 66.35 | 229.44 ± 69.66 | 234.80 ± 62.03 | 228.68 ± 70.88 | |
A: hypertension, b: body mass index, c: left ventricular ejection fraction, d: white blood cell, e: platelet, f: poor responder, g: responder